{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:55:04Z","timestamp":1792709704499,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec><jats:title>Abstract<\/jats:title><\/jats:sec><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are associated with osteoporosis. There have not been many peripheral quantitative computed tomography (QCT) studies in patients receiving biologics. We assessed volumetric and areal bone mineral density (BMD) by forearm QCT and dual-energy X-ray absorptiometry (DXA), respectively in addition to laboratory biomarkers in these arthritides.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Forty RA and AS patients treated with either etanercept (ETN) or certolizumab pegol (CZP) were undergoing follow-ups for one year. Volumetric and areal BMD, as well as parathyroid hormone (PTH), osteocalcin, RANKL, 25-hydroxyvitamin D (VITD), P1NP, CTX, sclerostin (SOST), Dickkopf 1 (DKK-1) and cathepsin K (CATHK) were determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We did not observe any further bone loss during the 12-month treatment period. Volumetric and areal BMD showed significant correlations with each other (p&lt;0.017 after Bonferroni\u2019s correction). Trabecular QCT BMD at baseline (p=0.015) and cortical QCT BMD after 12 months (p=0.005) were inversely determined by disease activity at baseline in the full cohort. Trabecular QCT BMD at baseline also correlated with CTX (p=0.011). In RA, CRP negatively (p=0.014), while SOST positively (p=0.013) correlated with different QCT parameters. In AS, RANKL at baseline (p=0.014) and after 12 months (p=0.007) correlated with cortical QCT BMD. In the full cohort, 12-month change in QTRABBMD was related to TNF inhibition together with elevated VITD-0 levels (p=0.031). Treatment and lower CATHK correlated with QCORTBMD changes (p=0.006). In RA, TNF inhibition together with VITD-0 (p&lt;0.01) or CATHK-0 (p=0.002), while in AS, treatment and RANKL-0 (p&lt;0.05) determined one-year changes in QCT BMD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>BMD as determined by QCT did not change over one year of anti-TNF treatment. Disease activity, CATHK, RANKL and VITD may be associated with the effects of anti-TNF treatment on QCT BMD changes. RA and AS may differ in this respect.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12891-021-04708-5","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T13:06:16Z","timestamp":1632402376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Bal\u00e1zs","family":"Juh\u00e1sz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Guly\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"V\u00e9gh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Pusztai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Szentp\u00e9tery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"Peth\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra","family":"Bodn\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Hamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levente","family":"Bodoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harjit Pal","family":"Bhattoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Hodosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Domj\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Szamosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Sz\u00e1nt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Sz\u0171cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hennie G.","family":"Raterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem F.","family":"Lems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"issue":"3","key":"4708_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11926-012-0253-7","volume":"14","author":"C Deal","year":"2012","unstructured":"Deal C. Bone loss in rheumatoid arthritis: systemic, periarticular, and focal. Curr Rheumatol Rep. 2012;14(3):231\u20137.","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"4708_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s11926-010-0122-1","volume":"12","author":"M Magrey","year":"2010","unstructured":"Magrey M, Khan MA. Osteoporosis in ankylosing spondylitis. Curr Rheumatol Rep. 2010;12(5):332\u20136.","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"4708_CR3","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s40266-019-00714-4","volume":"36","author":"HG Raterman","year":"2019","unstructured":"Raterman HG, Lems WF. Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide. Drugs Aging. 2019;36(12):1061\u201372.","journal-title":"Drugs Aging"},{"issue":"12","key":"4708_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","volume":"5","author":"H Takayanagi","year":"2009","unstructured":"Takayanagi H. Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol. 2009;5(12):667\u201376.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"4708_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ncprheum0036","volume":"1","author":"G Schett","year":"2005","unstructured":"Schett G, Hayer S, Zwerina J, Redlich K, Smolen JS. Mechanisms of Disease: the link between RANKL and arthritic bone disease. Nat Clin Pract Rheumatol. 2005;1(1):47\u201354.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"4708_CR6","doi-asserted-by":"crossref","unstructured":"Daoussis D, Andonopoulos AP, Liossis SN. Wnt Pathway and IL-17: Novel Regulators of Joint Remodeling in Rheumatic Diseases. Looking Beyond the RANK-RANKL-OPG Axis.\u00a0Semin Arthritis Rheum. 2010;39(5):369\u201383.","DOI":"10.1016\/j.semarthrit.2008.10.008"},{"issue":"2","key":"4708_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1084\/jem.191.2.275","volume":"191","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction. J Exp Med. 2000;191(2):275\u201386.","journal-title":"J Exp Med"},{"issue":"12","key":"4708_CR8","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000;106(12):1481\u20138.","journal-title":"J Clin Invest"},{"issue":"6","key":"4708_CR9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960\u201377.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4708_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.autrev.2017.01.014","volume":"16","author":"A Szentpetery","year":"2017","unstructured":"Szentpetery A, Horvath A, Gulyas K, Petho Z, Bhattoa HP, Szanto S, et al. Effects of targeted therapies on the bone in arthritides. Autoimmun Rev. 2017;16(3):313\u201320.","journal-title":"Autoimmun Rev"},{"key":"4708_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/1471-2474-15-289","volume":"15","author":"G Haugeberg","year":"2014","unstructured":"Haugeberg G, Helgetveit KB, Forre O, Garen T, Sommerseth H, Proven A. Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era. BMC Musculoskelet Disord. 2014;15:289.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"4708_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10067-019-04771-3","volume":"39","author":"K Gulyas","year":"2020","unstructured":"Gulyas K, Horvath A, Vegh E, Pusztai A, Szentpetery A, Petho Z, et al. Effects of 1-year anti-TNF-alpha therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol. 2020;39(1):167\u201375.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"4708_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.57.6.325","volume":"57","author":"WF Lems","year":"1998","unstructured":"Lems WF, Dijkmans BA. Should we look for osteoporosis in patients with rheumatoid arthritis? Ann Rheum Dis. 1998;57(6):325\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4708_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0030-5898(20)30459-4","volume":"16","author":"HK Genant","year":"1985","unstructured":"Genant HK, Ettinger B, Cann CE, Reiser U, Gordan GS, Kolb FO. Osteoporosis: assessment by quantitative computed tomography. Orthop Clin North Am. 1985;16(3):557\u201368.","journal-title":"Orthop Clin North Am"},{"issue":"4","key":"4708_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0001-2998(87)80024-7","volume":"17","author":"HK Genant","year":"1987","unstructured":"Genant HK, Block JE, Steiger P, Glueer CC, Smith R. Quantitative computed tomography in assessment of osteoporosis. Semin Nucl Med. 1987;17(4):316\u201333.","journal-title":"Semin Nucl Med"},{"issue":"1","key":"4708_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jocd.2007.12.010","volume":"11","author":"K Engelke","year":"2008","unstructured":"Engelke K, Adams JE, Armbrecht G, Augat P, Bogado CE, Bouxsein ML, et al. Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom. 2008;11(1):123\u201362.","journal-title":"J Clin Densitom"},{"issue":"10","key":"4708_CR17","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.3899\/jrheum.160645","volume":"43","author":"LS Tam","year":"2016","unstructured":"Tam LS. The Role of High-resolution Peripheral Quantitative Computed Tomography as a Biomarker for Joint Damage in Inflammatory Arthritis. J Rheumatol. 2016;43(10):1911\u20133.","journal-title":"J Rheumatol"},{"issue":"1","key":"4708_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF00290250","volume":"11","author":"M Felder","year":"1991","unstructured":"Felder M, Ruegsegger P. Bone loss in patients with rheumatoid arthritis--effect of steroids measured by low dose quantitative computed tomography. Rheumatol Int. 1991;11(1):41\u20134.","journal-title":"Rheumatol Int"},{"issue":"8","key":"4708_CR19","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/acr.23133","volume":"69","author":"J Yue","year":"2017","unstructured":"Yue J, Griffith JF, Xiao F, Shi L, Wang D, Shen J, et al. Repair of Bone Erosion in Rheumatoid Arthritis by Denosumab: A High-Resolution Peripheral Quantitative Computed Tomography Study. Arthritis Care Res. 2017;69(8):1156\u201363.","journal-title":"Arthritis Care Res"},{"key":"4708_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1471-2474-12-121","volume":"12","author":"M Korkosz","year":"2011","unstructured":"Korkosz M, Gasowski J, Grzanka P, Gorczowski J, Pluskiewicz W, Jeka S, et al. Baseline new bone formation does not predict bone loss in ankylosing spondylitis as assessed by quantitative computed tomography (QCT): 10-year follow-up. BMC Musculoskelet Disord. 2011;12:121.","journal-title":"BMC Musculoskelet Disord"},{"key":"4708_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bone.2019.01.024","volume":"122","author":"VF Caparbo","year":"2019","unstructured":"Caparbo VF, Furlam P, Saad CGS, Alvarenga JC, Aubry-Rozier B, Hans D, et al. Assessing bone impairment in ankylosing spondylitis (AS) using the trabecular bone score (TBS) and high-resolution peripheral quantitative computed tomography (HR-pQCT). Bone. 2019;122:8\u201313.","journal-title":"Bone"},{"issue":"9","key":"4708_CR22","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/art.1780350911","volume":"35","author":"JP Devogelaer","year":"1992","unstructured":"Devogelaer JP, Maldague B, Malghem J. Nagant de Deuxchaisnes C: Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography. Arthritis Rheum. 1992;35(9):1062\u20137.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"4708_CR23","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00198-016-3850-x","volume":"28","author":"B Juhasz","year":"2017","unstructured":"Juhasz B, Gulyas K, Horvath A, Petho Z, Bhattoa HP, Vancsa A, et al. Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls. Osteoporos Int. 2017;28(4):1271\u20137.","journal-title":"Osteoporos Int"},{"issue":"1","key":"4708_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13075-017-1430-x","volume":"19","author":"T Shimizu","year":"2017","unstructured":"Shimizu T, Choi HJ, Heilmeier U, Tanaka M, Burghardt AJ, Gong J, et al. Assessment of 3-month changes in bone microstructure under anti-TNFalpha therapy in patients with rheumatoid arthritis using high-resolution peripheral quantitative computed tomography (HR-pQCT). Arthritis Res Ther. 2017;19(1):222.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"4708_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3\u201315.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4708_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","volume":"77","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Schols M, Braun J, Dougados M, FitzGerald O, Gladman DD, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. 2018;77(1):3\u201317.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"4708_CR27","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/ard.2005.044198","volume":"65","author":"M Vis","year":"2006","unstructured":"Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ, et al. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65(11):1495\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4708_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/rheumatology\/kes320","volume":"52","author":"CL Krieckaert","year":"2013","unstructured":"Krieckaert CL, Nurmohamed MT, Wolbink G, Lems WF. Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study. Rheumatology (Oxford). 2013;52(3):547\u201353.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"4708_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00223-012-9644-z","volume":"91","author":"TY Zhu","year":"2012","unstructured":"Zhu TY, Griffith JF, Qin L, Hung VW, Fong TN, Kwok AW, et al. Bone density and microarchitecture: relationship between hand, peripheral, and axial skeletal sites assessed by HR-pQCT and DXA in rheumatoid arthritis. Calcif Tissue Int. 2012;91(5):343\u201355.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"4708_CR30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/acr.20394","volume":"63","author":"P Eser","year":"2011","unstructured":"Eser P, Aeberli D, Widmer J, Moller B, Villiger PM. Abnormal bone geometry at the metacarpal bone shaft of rheumatoid arthritis patients with maintained muscle-bone relationship. Arthritis Care Res. 2011;63(3):383\u20139.","journal-title":"Arthritis Care Res"},{"key":"4708_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1471-2474-14-367","volume":"14","author":"L Feehan","year":"2013","unstructured":"Feehan L, Buie H, Li L, McKay H. A customized protocol to assess bone quality in the metacarpal head, metacarpal shaft and distal radius: a high resolution peripheral quantitative computed tomography precision study. BMC Musculoskelet Disord. 2013;14:367.","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"4708_CR32","doi-asserted-by":"publisher","first-page":"R62","DOI":"10.1186\/ar4235","volume":"15","author":"S Aschenberg","year":"2013","unstructured":"Aschenberg S, Finzel S, Schmidt S, Kraus S, Engelke K, Englbrecht M, et al. Catabolic and anabolic periarticular bone changes in patients with rheumatoid arthritis: a computed tomography study on the role of age, disease duration and bone markers. Arthritis Res Ther. 2013;15(3):R62.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"4708_CR33","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3899\/jrheum.160648","volume":"43","author":"C Barnabe","year":"2016","unstructured":"Barnabe C, Toepfer D, Marotte H, Hauge EM, Scharmga A, Kocijan R, et al. Definition for Rheumatoid Arthritis Erosions Imaged with High Resolution Peripheral Quantitative Computed Tomography and Interreader Reliability for Detection and Measurement. J Rheumatol. 2016;43(10):1935\u201340.","journal-title":"J Rheumatol"},{"issue":"4","key":"4708_CR34","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3899\/jrheum.120780","volume":"40","author":"W Srikhum","year":"2013","unstructured":"Srikhum W, Virayavanich W, Burghardt AJ, Yu A, Link TM, Imboden JB, et al. Quantitative and semiquantitative bone erosion assessment on high-resolution peripheral quantitative computed tomography in rheumatoid arthritis. J Rheumatol. 2013;40(4):408\u201316.","journal-title":"J Rheumatol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04708-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04708-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04708-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T19:02:44Z","timestamp":1725822164000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04708-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4708"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04708-5","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"8 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Hungarian Scientific Research Council Ethical Committee (approval No. 14804-2\/2011\/EKU). Written informed consent was obtained from each patient and assessments were carried out according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients gave informed consent to use their clinical data for the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have any competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"817"}}